info@biomedres.us
+1 (502) 904-2126
One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA
Site Map
ISSN: 2574 -1241
ISSN: 2574 -1241
Received: December 08, 2017; Published: December 13, 2017
DOI: 10.26717/BJSTR.2017.01.000587
The mandibular hyperparathyroid brown tumour is considered a rare metabolic disorder, also known as mandibular osteoclastome, therefore its therapy is not well defined yet; This lesion is triggered by the excess of the production of PTH parathyroid hormone, which are directly linked to mechanisms of control of levels of calcium, phosphorus and vitamin D, which confers the lesions the aspect of numerous osteoclastic cells, circumscribed and richly vascularised Which causes their reddish-brown coloration, individuals affected by this disorder show signs and symptoms of weakness, nausea, fatigue, anorexia, excessive thirst, polyuria, constipation and consequently depression, the purpose of this study is to perform a literature review by describing the case of mandibular brown tumour, explaining the conduct performed according to the case by clinical, laboratory analysis and image studies that guided the case.
Summary| Introduction| Literature Review| Case Report| Discussion| Final Consideration| References|
International Association of Landscape Archaeology, Czech Glass Society, Czech Republic
Department of Chemistry, Semenov Institute of Chemical Physics, USSR Academy of Sciences, Moscow, Russia
Pharmaco-kinetics, dynamics and Drug Metabolism, Touro College of Pharmacy, USA
Professor of Nuclear Medicine, Faculty of Medicine and Surgery, University of Milan, Milan, Italy
Clinical Radiologist (MD) - Department of RADIOLOGY, Cosenza Hospital, Cosenza, Italy
Full Text
PDF
